Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 411

1.

Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme.

Smith KA, Ashby LS, Gonzalez LF, Brachman DG, Thomas T, Coons SW, Battaglia M, Scheck A.

J Neurosurg. 2008 Dec;109 Suppl:106-17. doi: 10.3171/JNS/2008/109/12/S17. Erratum in: J Neurosurg. 2009 Jun;110(6):1323-4. J Neurosurg. 2009 Sep;111(3):639. Gonzalez, Fernando [corrected to Gonzales, L Fernando].

PMID:
19123896
[PubMed - indexed for MEDLINE]
2.

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.

McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2009 Mar;110(3):583-8. doi: 10.3171/2008.5.17557.

PMID:
19046047
[PubMed - indexed for MEDLINE]
3.

Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.

Noël G, Schott R, Froelich S, Gaub MP, Boyer P, Fischer-Lokou D, Dufour P, Kehrli P, Maitrot D.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):749-55. doi: 10.1016/j.ijrobp.2010.11.073. Epub 2011 Feb 6.

PMID:
21300471
[PubMed - indexed for MEDLINE]
4.

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.

Bock HC, Puchner MJ, Lohmann F, Schütze M, Koll S, Ketter R, Buchalla R, Rainov N, Kantelhardt SR, Rohde V, Giese A.

Neurosurg Rev. 2010 Oct;33(4):441-9. doi: 10.1007/s10143-010-0280-7. Epub 2010 Aug 13.

PMID:
20706757
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

Kleinberg LR, Weingart J, Burger P, Carson K, Grossman SA, Li K, Olivi A, Wharam MD, Brem H.

Cancer Invest. 2004;22(1):1-9.

PMID:
15069758
[PubMed - indexed for MEDLINE]
6.

O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.

Lechapt-Zalcman E, Levallet G, Dugué AE, Vital A, Diebold MD, Menei P, Colin P, Peruzzy P, Emery E, Bernaudin M, Chapon F, Guillamo JS.

Cancer. 2012 Sep 15;118(18):4545-54. doi: 10.1002/cncr.27441. Epub 2012 Feb 22.

PMID:
22359215
[PubMed - indexed for MEDLINE]
Free Article
7.

Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.

Subach BR, Witham TF, Kondziolka D, Lunsford LD, Bozik M, Schiff D.

Neurosurgery. 1999 Jul;45(1):17-22; discussion 22-3.

PMID:
10414561
[PubMed - indexed for MEDLINE]
8.

Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.

Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H.

Ann Surg Oncol. 2008 Oct;15(10):2887-93. doi: 10.1245/s10434-008-0048-2. Epub 2008 Jul 18.

PMID:
18636295
[PubMed - indexed for MEDLINE]
9.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy.

McPherson CM, Gerena-Lewis M, Breneman JC, Warnick RE.

J Neurooncol. 2012 Jul;108(3):521-5. doi: 10.1007/s11060-012-0854-z. Epub 2012 Apr 1.

PMID:
22467191
[PubMed - indexed for MEDLINE]
12.

Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.

Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1066-74. doi: 10.1016/j.ijrobp.2010.07.021. Epub 2010 Oct 6.

PMID:
20932651
[PubMed - indexed for MEDLINE]
13.

Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.

Einstein DB, Wessels B, Bangert B, Fu P, Nelson AD, Cohen M, Sagar S, Lewin J, Sloan A, Zheng Y, Williams J, Colussi V, Vinkler R, Maciunas R.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):668-74. doi: 10.1016/j.ijrobp.2012.01.020. Epub 2012 Mar 22.

PMID:
22445005
[PubMed - indexed for MEDLINE]
14.

Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity.

Miglierini P, Bouchekoua M, Rousseau B, Hieu PD, Malhaire JP, Pradier O.

Clin Neurol Neurosurg. 2012 Nov;114(9):1222-5. doi: 10.1016/j.clineuro.2012.02.056. Epub 2012 Mar 31.

PMID:
22464950
[PubMed - indexed for MEDLINE]
15.

The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.

Barr JG, Grundy PL.

Br J Neurosurg. 2012 Dec;26(6):818-22. doi: 10.3109/02688697.2012.697221. Epub 2012 Jun 21.

PMID:
22715955
[PubMed - indexed for MEDLINE]
16.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
[PubMed - indexed for MEDLINE]
17.

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.

Westphal M, Ram Z, Riddle V, Hilt D, Bortey E; Executive Committee of the Gliadel Study Group.

Acta Neurochir (Wien). 2006 Mar;148(3):269-75; discussion 275. Epub 2006 Feb 17.

PMID:
16482400
[PubMed - indexed for MEDLINE]
18.

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, Barrie M, Chinot O, Fuentes S, Dufour H, Ouafik L, Figarella-Branger D.

Cancer. 2009 Oct 15;115(20):4783-94. doi: 10.1002/cncr.24546.

PMID:
19637364
[PubMed - indexed for MEDLINE]
Free Article
19.

MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.

Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, Lee KS, Suh CO.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):661-7. doi: 10.1016/j.ijrobp.2011.12.086. Epub 2012 Mar 11.

PMID:
22414280
[PubMed - indexed for MEDLINE]
20.

Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.

Lipani JD, Jackson PS, Soltys SG, Sato K, Adler JR.

Technol Cancer Res Treat. 2008 Jun;7(3):249-55.

PMID:
18473497
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk